CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÀÌÁ¦È£
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ
  • Á÷ À§: ±³¼ö(÷´Ü¿¬±¸¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
12 ÇØ¿Ü Kim TJ, Lee YY, Cha HH, Kim CJ, Choi CH, Lee JW, Bae DS, Lee JH, Kim BG. Single port access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: A comparison of perioperative outcomes. Surgical Endoscopy And Other Interventional Techniques 24(9):2248-2252, September 2010.  
11 ÇØ¿Ü Lee EJ, McClelland M, Wang Y, Long F, Choi SH, Lee JH. Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix. Oncology Research 18(9):401-408, September 2010.  
10 ÇØ¿Ü Lee YY, Lee JW, Park HS, Song TJ, Kim MK, Choi CH, Kim TJ, Lee JH, Bae DS, Kim BG. Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer. Gynecologic Oncology 119(1):87-91, October 2010.  
9 ÇØ¿Ü Lee JH, Lee SY, Lee JH, Lee SH. p21 is involved in interferon-B-induced attenuation of teolmerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer. Molecules and Cells 30(4):327-333, October 2010.  
8 ÇØ¿Ü Nam H, Huh SJ, Park W, Bae DS, Kim BG, Lee JH, Kim CK, Park BK. Prognostic significance of MRI-detected bladder muscle and/or serosal invasion in patients with cervical cancer treated with radiotherapy. The British Journal of Radiology 83(994):868-873, October 2010.  
7 ÇØ¿Ü Hwang JR, Huh JH, Lee YN, Lee SI, Rho SB, Lee JH. Insulin-like growth factor-binding protein-5 (IGFBP-5) inhibits TNF-a-induced NF-kB activity by binding to TNFR1. Biochemical and Biophysical Research Communications 405(4):545-551, February 2011.  
6 ÇØ¿Ü Park KS, Chung YJ, So HK, Kim KS, Park JS, Oh MJ, Jo MW, Choi KS, Lee EJ, Choi YL, Song SY, Bae DS, Kim BG, Lee JH. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mole Med 43(2):91-100, 2011.  
5 ÇØ¿Ü Lee YY, Choi CH, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA. Gynecologic Oncology 120(3):439-443, March 2011.  
4 ÇØ¿Ü Choi CH, Lee JS, Kim SR, Lee YY, Kim CJ, Lee JW, Kim TJ, Lee JH, Kim BG, Bae DS. Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma. Journal of Cancer Research and Clinical Oncology 137(3):463-469, March 2011.  
3 ÇØ¿Ü Choi CH, Lee YY, Song TJ, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG. Phase II Study of Belotecan, a Camptothecin Analog, in Combination with Carboplatin for the Treatment of Recurrent Ovarian Cancer. Cancer 117(10):2104-2111, May 2011.  
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729